Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Anatol Kreitzer, Chief Discovery Officer of MapLight Therapeutics, Inc., sold 12,248 shares of common stock on October 15, 2026 for $7.84 per share.
Summary
- Open-market sale: disposed of 12,248 Voting Common Stock at $7.84 ($96,024) on October 15, 2026; holds 168,678 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $96,024 of stock on the open market.
Insider Transactions
Anatol Kreitzer — Officer (Chief Discovery Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Open-market sale | Voting Common Stock | 12,248 | $8 | $96.0K | 168,678 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Open-market sale (12,248 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Anatol Kreitzer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.